Encompass Health Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated May 1, 2025, details the outcomes of Encompass Health Corporation's 2025 Annual Meeting of Stockholders. The filing addresses corporate governance actions, including the election of directors, ratification of auditors, and approval of executive compensation and incentive plans.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and voting results.
Material Changes and Voting Results
Stockholders representing 93.9% of the combined voting power participated in the Annual Meeting. The following matters were approved:
- Election of Directors: All 10 nominees were elected. Votes ranged from approximately 87.8 million to 89.8 million "For" votes per nominee.
- Auditor Ratification: PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm with 91,374,755 votes in favor.
- Executive Compensation: The compensation of named executive officers was approved with 87,426,450 votes in favor.
- Incentive Plan: The 2025 Omnibus Performance Incentive Plan was approved with 85,524,738 votes in favor.
As of the record date, there were 100,967,059 shares of common stock issued and outstanding.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors. It serves as a disclosure of the completed voting process and the adoption of the 2025 Omnibus Performance Incentive Plan.
Key Facts for Investor Verification
- Verify the specific terms and share limits of the newly approved 2025 Omnibus Performance Incentive Plan (Exhibit 10.1).
- Review the proxy statement filed on April 1, 2025, for detailed disclosures regarding the approved executive compensation.
- Confirm the composition of the newly elected Board of Directors and their tenure.
- Note that the filing contains no operational or financial results for the period ending May 1, 2025.